Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110508323B details a water-phase Henry reaction using a recyclable thermosensitive chiral copper catalyst, offering high enantioselectivity and simplified downstream processing for pharmaceutical intermediates.
Patent CN105017269A reveals a novel organocatalytic route for high-purity chiral spiro oxindole derivatives, offering significant cost reduction and scalable manufacturing advantages for pharmaceutical supply chains.
Patent CN112300151B enables efficient Maropitant intermediate production. Reduced steps and high ee value ensure cost reduction in pharmaceutical manufacturing.
Patent CN111995620A reveals a KHSO4-catalyzed route for 1,3,4-thiadiazoles, offering cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN110724115B reveals a green synthesis route for thiadiazoles using choline chloride-urea DES, offering high purity and reduced environmental impact for pharmaceutical manufacturing.
Patent CN101274923B reveals a novel nitrate-catalyzed method for selective acylation, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN103709212A reveals a novel three-step synthesis improving purity and yield. Discover cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN102899367B details a hybrid bio-chemical synthesis for high-purity Tenofovir. This method offers significant cost reduction and scalable manufacturing for API intermediates.
Patent CN103694288A reveals a novel three-step route for high-purity pharmaceutical intermediates. This method ensures cost reduction and supply chain reliability.
Patent CN112812060B reveals a metal-free, visible-light driven arylation method for tetrahydroquinoline derivatives, offering green synthesis routes for pharmaceutical intermediates.
Patent CN103772151A reveals a cost-effective chlorination-esterification route for 2-methyl-3-phenyl benzyl alcohol, offering significant supply chain advantages for bifenthrin production.
Novel palladium-catalyzed decarboxylative [5+3] cycloaddition patent offers high enantioselectivity and mild conditions for scalable pharmaceutical intermediates manufacturing supply chain.
Patent CN106632086B details a Rhodium-catalyzed C-H iodination method for quinazolines. This process offers high purity, mild conditions, and significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN102603714B details a high-yield asymmetric oxidation method for PPI intermediates. Discover cost-effective manufacturing and supply chain advantages.
Patent CN116082111B reveals chromium catalysis for 1,1,2-triarylethane. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN102070497B reveals a novel four-step synthesis for florfenicol. This method offers mild conditions and high yields, ensuring cost reduction and supply chain reliability for global buyers.
Novel binaphthyl-based phase transfer catalyst offering high enantioselectivity up to 98% ee. Ideal for pharmaceutical intermediates manufacturing with scalable processes.
Novel copper complex synthesis offers enhanced antitumor activity and scalable manufacturing processes for global pharmaceutical supply chains.
Advanced Lewis acid-catalyzed synthesis of Ezetimibe intermediates offers high purity and mild conditions, ensuring cost-effective supply for cardiovascular drug manufacturing.
Novel copper-catalyzed route for 2-azabicyclo[3.2.0] intermediates offers mild conditions and high yields, ensuring reliable supply chain solutions.